|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 61 - 90 of 137 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Zoladex 3.6 mg implantaatti SPC 2023-04-21
|
|
|
European Medicines Agency's website: Zoledronic Acid Accord - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Zoledronic Acid Fresenius Kabi infuusiokonsentraatti, liuosta varten SPC 2021-09-23
|
|
|
European Medicines Agency's website: Zoledronic acid Mylan - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Zoledronic Acid Oresund Pharma 4 mg-100 ml infuusioneste, liuos SPC 2024-04-24
|
PL
|
Resepti
|
Zoledronic Acid Oresund Pharma 5 mg-100 ml infuusioneste, liuos SPC 2024-04-24
|
PL
|
Resepti
|
Zoledronic acid STADA 4 mg-100 ml infuusioneste, liuos SPC 2020-08-28
|
PL
|
Resepti
|
Zoledronic acid Sun 5 mg infuusioneste, liuos SPC 2021-12-20
|
PL
|
Resepti
|
Zoledronic acid SUN Pharma 5 mg-100ml infuusioneste, liuos SPC 2024-07-27
|
|
|
European Medicines Agency's website: Zoledronic acid Teva - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Zolestad 5 mg - 100 ml infuusioneste, liuos SPC 2024-04-02
|
|
|
European Medicines Agency's website: Zolgensma - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Zolmistad 2,5 mg tabletti, suussa hajoava SPC 2021-11-12
|
PL
|
Resepti
|
Zolmitriptan Sandoz 2.5 mg tabletti, suussa hajoava SPC 2021-06-29
|
PL
|
Resepti
|
Zolmitriptan stada 2,5 mg, tabletti SPC 2022-30-30.doc
|
PL
|
Resepti
|
Zoloft 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2024-04-02
|
PL
|
Resepti
|
Zolpidem Vitabalans 10 mg tabletti, kalvopäällysteinen SPC 2023-10-12
|
|
|
European Medicines Agency's website: ZOLSKETIL pegylated liposomal - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti/itsehoito
|
Zolt 15 mg, 30 mg enterokapseli, kova SPC 2023-09-11
|
PL
|
Resepti
|
Zomacton 10 mg injektiokuiva-aine ja liuotin SPC 2021-06-15
|
|
|
European Medicines Agency's website: Zomarist - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Zometa - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Zomig 2.5 mg, 5 mg tabletti, kalvopäällysteinen SPC 2022-06-22
|
PL
|
Resepti
|
Zomig Nasal 2.5 mg-annos, 5 mg-annos, nenäsumute SPC 2023-07-25
|
PL
|
Resepti
|
Zomig Rapimelt 2,5 mg, 5 mg tabletti, suussa hajoava SPC 2024-06-14
|
PL
|
Resepti
|
Zomig Rapimelt 2,5 mg, 5 mg tabletti, suussa hajoava SPC 2024-06-14
|
PL
|
Resepti
|
Zomylac 80 mg/ml + 16 mg/ml infuusiokonsentraatti, liuosta varten SPC 2024-01-30
|
|
|
European Medicines Agency's website: Zonegran - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Zonisamide STADA 50 mg, 100 mg kapseli, kova SPC 2023-03-09
|
|
|
European Medicines Agency's website: Zonisamide Viatris (ent. Zonisamide Mylan) - EMA: EPAR PI
Finnish Swedish
|
|
| |